Company news

Twist Bioscience Corporation (NASDAQ:TWST) news

Twist Bioscience Corporation news releases on 6ix. Latest, Sep 16, 2026: Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery

View Twist Bioscience Corporation →

Press releases & updates

Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery

September 16, 2026

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(4)

August 5, 2026

Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock

August 4, 2026

Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results

August 3, 2026

Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026

July 15, 2026

Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference

May 27, 2026

LenioBio and Twist Bioscience Enter into a Collaboration to Further Enable AI drug-discovery

May 8, 2026

Benchling Launches One-Click Ordering for Biopharma R&D with Twist Bioscience, Adaptyv, and Ginkgo Bioworks

May 6, 2026

Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences

May 4, 2026

Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results

May 4, 2026

Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026

April 21, 2026

Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement

February 17, 2026

Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes

February 10, 2026

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

February 2, 2026

Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results

February 2, 2026

Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue

January 11, 2026

Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference

December 17, 2025

Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research

December 3, 2025

Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results

November 13, 2025

Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference

November 3, 2025

Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025

October 22, 2025

Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle™ Sequencing Workflow for the AVITI™ System

October 5, 2025

Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design

October 1, 2025

Twist Bioscience to Present at Baird 2025 Global Healthcare Conference

September 2, 2025

Twist Bioscience Collaborates with Synthetic Design Lab

September 1, 2025

Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution

August 18, 2025

Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors

August 5, 2025

Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results

August 3, 2025

Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model

July 30, 2025

Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

July 23, 2025

Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025

July 13, 2025

Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format

July 6, 2025

Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions

May 21, 2025

Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference

May 14, 2025

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

May 7, 2025

Twist Bioscience Spins Out DNA Data Storage as Independent Company

May 4, 2025

Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results

May 4, 2025

Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System

April 23, 2025

Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025

April 13, 2025

Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics

March 30, 2025

Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost

March 10, 2025

Twist Bioscience to Present at Upcoming Investor Conferences

February 24, 2025

Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results

February 2, 2025

Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025

January 21, 2025

Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference

December 18, 2024

Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results

November 17, 2024

Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference

November 13, 2024

Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics

October 29, 2024

Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024

October 23, 2024

Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash

October 21, 2024

Older →